Introduction of Tixagevimab and Cilgavimab Monoclonal Antibody into Muscle, Percutaneous Approach, New Technology Group 7 XW023X7

ICD-10-PCS code XW023X7 for Introduction of Tixagevimab and Cilgavimab Monoclonal Antibody into Muscle, Percutaneous Approach, New Technology Group 7 is a medical classification as listed by CMS under Anatomical Regions range.

Image 2

Official Code Descriptor

Introduction of Tixagevimab and Cilgavimab Monoclonal Antibody into Muscle, Percutaneous Approach, New Technology Group 7

Crosswalks

Tabs

No record found

Crosswalk an ICD-10-PCS code to CPT®

Additional/Related Information

Tabs
Section(X)Body System(W)Operation(0)Body Part(2)Approach(3)Device / Substance / Technology(X)Qualifier(7)
New TechnologyAnatomical RegionsIntroductionMusclePercutaneousTixagevimab and Cilgavimab Monoclonal AntibodyNew Technology Group 7

No record found

Change TypeChange DatePrevious Descriptor
Code Added 10-01-2021
No need to flip from a code to the front of a book or to hunt through online PDFs to locate applicable chapter and block specific guidelines. See essential instructions from ICD-10-PCS Official Guidelines for Coding and Reporting right on your code details page.

Forum

Have a question about ICD-10-PCS XW023X7 ? Start a discussion here